SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

26 Jun 2008 12:23

RNS Number : 6132X
Rentokil Initial PLC
26 June 2008
Ā 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anĀ issuerĀ to make aĀ RISĀ notification required byĀ DRĀ 3.1.4R(1).

Ā 

(1)

AnĀ issuerĀ making a notification in respect of a transaction relating to theĀ sharesĀ or debentures of theĀ issuerĀ should completeĀ boxes 1 to 16, 23 and 24.

(2)

AnĀ issuerĀ making a notification in respect of a derivative relatingĀ toĀ theĀ sharesĀ of theĀ issuerĀ should completeĀ boxes 1 to 4, 6, 8,Ā 13, 14, 16, 23 and 24.Ā 

(3)

AnĀ issuerĀ making a notification in respect of options granted to aĀ director/person discharging managerial responsibilitiesĀ should completeĀ boxes 1 to 3Ā and 17 to 24.Ā 

(4)

AnĀ issuerĀ making a notification in respect of aĀ financial instrumentĀ relating to theĀ sharesĀ of theĀ issuerĀ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Ā 

Ā 

Please complete all relevant boxes in block capital letters.

1.Ā Name of theĀ issuer

Rentokil Initial plc

2.Ā State whether the notification relates to (i) a transaction notified in accordance withĀ DRĀ 3.1.4R(1)(a); or

(ii)Ā DRĀ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orĀ 

(iii) both (i) and (ii)

Pursuant toĀ (i) and (ii) above

3.Ā Name ofĀ person discharging managerial responsibilities/director

Andrew Macfarlane

Henry Chandler

Petar Cvetkovic

Andy Hobart

Andy Kemp

Bryan Kinsella

David Liu

Peter Lloyd

4.Ā State whether notification relates to aĀ personĀ connected with aĀ person discharging managerial responsibilities/directorĀ named in 3 and identify theĀ connected person

Not applicable

5.Ā Indicate whether the notification is in respect of a holding of theĀ personĀ referred to in 3 or 4 above or in respect of a non-beneficial interest

Pursuant to 3. above

6.Ā Description ofĀ sharesĀ (includingĀ class), debentures or derivatives or financial instruments relating toĀ shares

Ordinary shares of 1 pence each

7.Ā Name of registered shareholders(s) and, if more than one, the number ofĀ sharesĀ held by each of them

Not applicable

8.Ā State the nature of the transaction

Awards under theĀ 2006Ā Performance Share PlanĀ - 2008 award

9.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ acquired

Not applicable

10.Ā Percentage of issuedĀ classĀ acquired (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)

Not applicable

11.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ disposed

Not applicable

12.Ā Percentage of issuedĀ classĀ disposed (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)Ā 

Not applicable

13.Ā Price perĀ shareĀ or value of transaction

Not applicable

14.Ā Date and place of transaction

Not applicable

15.Ā Total holding following notification and total percentage holding following notification (anyĀ treasury sharesĀ should not be taken into account when calculating percentage)

Not applicable

16.Ā Date issuer informed of transaction

25 June 2008

If aĀ person discharging managerial responsibilitiesĀ has been granted options by theĀ issuerĀ complete the following boxes

17.Ā Date of grant

25Ā June 2008Ā - Performance Share Plan award

18.Ā Period during which or date on which it can be exercised

26Ā JuneĀ 2011Ā toĀ 25Ā June 2018Ā (subject to performance conditions)

19.Ā Total amount paid (if any) for grant of the option

Nil

20.Ā Description ofĀ sharesĀ or debentures involved (classĀ and number)

Ordinary shares of 1 pence each

Andrew MacfarlaneĀ  1,248,000 Performance share plan awards

Henry ChandlerĀ  840,000 Performance share plan awards

Petar CvetkovicĀ  1,120,000 Performance share plan awards

Andy HobartĀ  804,000 Performance share plan awards

Andy KempĀ  710,400 Performance share plan awards

Bryan Kinsella 544,800Ā  Performance share plan awards

David Liu 811,670 Performance share plan awards

Peter Lloyd 506,880 Performance share plan awards

Ā 

21.Ā Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Nil

22.Ā Total number ofĀ sharesĀ or debentures over which options held following notification

Ā 

a. Andrew Macfarlane 2,001,197Ā  Performance share plan awards

Ā 

b. Henry Chandler 1,332,296Ā  Performance share awards

527,286Ā  Pre 2006 ESOS share options

Ā 

c. Petar Cvetkovic 1,120,000 Performance share plan awards

Ā 

d. Andy Hobart 1,300,763 Performance shareĀ planĀ awards

Ā 

e. Andy Kemp 1,155,914Ā  Performance shareĀ planĀ awards

Ā 

f. Bryan Kinsella 624,438 Performance share plan awards

Ā 

g. David LiuĀ  1,334,676 Performance shareĀ planĀ awards

Ā 

h. Peter Lloyd 1,029,886Ā  Performance share plan awards

166,619Ā  Pre 2006 ESOS share options

23.Ā Any additional information

Not applicable

24.Ā Name of contact and telephone number for queries

Paul Griffiths,Ā Company SecretaryĀ -Ā 020Ā 7592 2700

25.Ā Name and signature of duly authorised officer ofĀ issuerĀ responsible for making notification

Paul Griffiths, Company Secretary

26.Ā Date of notification

26 June 2008

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDSBBGDLIBDGGIL
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.